Regis Corp: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 13, 2025 and accepted by EDGAR at May 13, 2025, 06:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $57.0m | us-gaap:Revenues |
| Revenue | 9 months2024-07-01 to 2025-03-31 | $149.7m | us-gaap:Revenues |
| Operating income | 3 months2025-01-01 to 2025-03-31 | $5.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-07-01 to 2025-03-31 | $12.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-01-01 to 2025-03-31 | $5.1m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 9 months2024-07-01 to 2025-03-31 | $14.8m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2025-01-01 to 2025-03-31 | −$1.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-07-01 to 2025-03-31 | −$90.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-31 | $250.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-07-01 to 2025-03-31 | $7.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | $0.08 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-07-01 to 2025-03-31 | $3.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | $0.10 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-07-01 to 2025-03-31 | $3.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 3,002,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-07-01 to 2025-03-31 | 2,350,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-07-01 to 2025-03-31 | $7.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-07-01 to 2025-03-31 | $769.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-03-31 | $13.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $47.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $511.2m | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $101.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $442.6m | us-gaap:Liabilities |
| Long-term debt | At period end2025-03-31 | $112.0m | us-gaap:LongTermDebtNoncurrent |
Source: SEC EDGAR, the filing index for accession 0000716643-25-000021. Last ingested by Listed: Oct 30, 2026, 18:10 ET. Listed shows no prices and gives no investment advice.